COLUMBUS, Ohio–(BUSINESS WIRE)–HealthPlan Data Solutions (HDS), the industry leader in pharmacy payment integrity and benefit optimization, today announced a $15 million growth equity investment led by MK Capital, with participation from existing investors Tamarind Hill, JobsOhio, and Rev1 Ventures.

“This investment allows us to expand our technology platform, develop more robust analytics, and enhance service capabilities so health plans and employers can take control of their pharmacy spend in real-time—not months after the fact,” said CEO, Ron HammShare

Since its inception, HDS has saved payers millions and protected more than 8 million covered lives by identifying overpayments to Pharmacy Benefit Managers (PBMs), eliminating contractual gray areas, optimizing plan design and helping uphold plan sponsors’ fiduciary responsibilities under ERISA.

As pharmacy costs continue to climb, health plans and employers urgently need smarter, more proactive tools to monitor claims and control costs. HDS’s Claim Scan solution continuously monitors 100% of pharmacy claims in near real-time, using over 500 customizable algorithms to detect adjudication errors before they lead to excess costs. Unlike retrospective one-time audits, HDS provides continuous oversight, allowing plan sponsors to detect and recover claim-level errors before they escalate, uncover trends that expose contract misalignment or hidden overcharges, and strengthen PBM contracts to drive better long-term cost controls.

“This investment allows us to expand our technology platform, develop more robust analytics, and enhance service capabilities so health plans and employers can take control of their pharmacy spend in real-time—not months after the fact,” said CEO, Ron Hamm. “We can now fully realize our mission to bring transparency, accountability, and efficiency to pharmacy leaders searching for better answers in today’s opaque PBM review process.”

“We are thrilled to partner with HDS at this pivotal time,” noted Mark Koulogeorge, Managing Partner at MK Capital. “With bipartisan calls for PBM reform and rising prescription drug costs, sophisticated payers recognize they have a responsibility to take back control of their pharmacy benefit. HDS’s solution pays for itself within months and provides customers the assurance that their members’ pharmacy benefit is being properly administered.”

Hamm went on to say that clients should expect to see more automated workflows, additional Claim Scan algorithms, and ease-of-use improvements in the near future that will drive added value and efficiency to our near real-time pharmacy benefit review solutions.

Additional information regarding HDS’s continuous pharmacy benefit monitoring solution, Claim Scan, can be found on their website at hds-rx.com.

About MK Capital

MK Capital is an early and growth-stage venture capital firm with more than $500 million in assets under management that invests in disruptive business-to-business software and technology companies. The MK partners average over twenty years of venture capital experience and have built dozens of leading companies in their chosen markets. As a member of the MK Capital portfolio, companies gain access to experienced partners with deep operating experience, not just a line of capital. MK collaborates on strategy, operations, and technology as active board members, leveraging deep insights to drive growth and scale.

About HealthPlan Data Solutions

HealthPlan Data Solutions (HDS) is an industry leading pharmacy analytics company that specializes in providing pharmacy payment integrity solutions, campaign management, and pharmacy claims insights. HDS’s technology platform, Spotlight, leverages over 500 proprietary claim scanning algorithms and AI, matched with clinical expertise to provide actionable pharmacy benefit intelligence.

Founded by a team of pharmacists and IT professionals, HDS helps its customers identify, fix, and continuously monitor prescription claims data to maximize the value of their pharmacy benefit plans.

Contacts

MEDIA CONTACT: Jeff Baldetti, Vice President, Marketing and Product jeff.baldetti@hds-rx.com

(c)2025 Business Wire, Inc., All rights reserved.